Innovation for a healthier world: How the research-based vaccine manufacturers are contributing to the Decade of vaccines action plan

Statement 5 Jun 2023

G20 3rd Health Working Group Meeting: Health Emergencies Prevention, Preparedness, and Response (HEPPR)

On 4 June, IFPMA delivered a statement on Priority I “Health Emergencies Prevention, Preparedness, and Response” at the G20 3rd Health Working Group Meeting in Hyderabad.

G20 3rd Health Working Group Meeting: Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)

On 4 June, IFPMA delivered a statement on Priority II “Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)” at the G20 3rd Health Working Group Meeting in Hyderabad.

G20 side event on Global Vaccine Research Collaborative

On 3 June, IFPMA delivered a statement at the PATH and CEPI side event on the “Global Vaccine Research Collaborative” at the G20 3rd Health Working Group Meeting in Hyderabad.